• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

活性HIV-1逆转录酶起始复合物的组装、纯化及结晶

Assembly, purification and crystallization of an active HIV-1 reverse transcriptase initiation complex.

作者信息

Pata Janice D, King Bradford R, Steitz Thomas A

机构信息

Department of Molecular Biophysics and Biochemistry, Yale University, New Haven, CT 06520-8114, USA.

出版信息

Nucleic Acids Res. 2002 Nov 15;30(22):4855-63. doi: 10.1093/nar/gkf620.

DOI:10.1093/nar/gkf620
PMID:12433988
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC137168/
Abstract

Human immunodeficiency virus type 1 (HIV-1) reverse transcriptase (RT) initiates DNA synthesis from the 3' end of human tRNA(Lys3). We have used cis-acting hammerhead ribozymes to produce homogeneous-length transcribed tRNA(Lys3) and have developed conditions for purifying highly structured RNAs on a modified tube-gel apparatus. Titration experiments show that this RNA can assemble into an initiation complex that contains equimolar amounts of HIV-1 RT, transcribed tRNA(Lys3), and chemically synthesized template RNA. We have purified this complex using gel-filtration chromatography and have found that it is homogeneous with respect to molecular weight, demonstrating that the initiation complex forms a single discrete species at micromolar concentrations. When this initiation complex is supplied with deoxynucleotides, essentially all of the tRNA is used as a primer by HIV-1 RT and is fully extended to the 5' end of the template. Thus, in vitro transcribed tRNA can be used efficiently as a primer by HIV-1 RT. We have also obtained crystals of the HIV-1 initiation complex that require the precisely defined ends of this in vitro transcribed tRNA(Lys3) to grow.

摘要

1型人类免疫缺陷病毒(HIV-1)逆转录酶(RT)从人tRNA(Lys3)的3'末端起始DNA合成。我们利用顺式作用锤头状核酶产生均一长度的转录tRNA(Lys3),并开发了在改良的管凝胶装置上纯化高度结构化RNA的条件。滴定实验表明,这种RNA能组装成一个起始复合物,该复合物包含等摩尔量的HIV-1 RT、转录的tRNA(Lys3)和化学合成的模板RNA。我们使用凝胶过滤色谱法纯化了该复合物,发现其分子量均一,这表明起始复合物在微摩尔浓度下形成单一离散物种。当向该起始复合物提供脱氧核苷酸时,基本上所有的tRNA都被HIV-1 RT用作引物,并完全延伸至模板的5'末端。因此,体外转录的tRNA可被HIV-1 RT有效地用作引物。我们还获得了HIV-1起始复合物的晶体,这些晶体需要这种体外转录的tRNA(Lys3)的精确界定末端才能生长。

相似文献

1
Assembly, purification and crystallization of an active HIV-1 reverse transcriptase initiation complex.活性HIV-1逆转录酶起始复合物的组装、纯化及结晶
Nucleic Acids Res. 2002 Nov 15;30(22):4855-63. doi: 10.1093/nar/gkf620.
2
p66/p51 and p51/p51 recombinant forms of reverse transcriptase from human immunodeficiency virus type 1--interactions with primer tRNA(Lys3), initiation of cDNA synthesis, and effect of inhibitors.1型人类免疫缺陷病毒逆转录酶的p66/p51和p51/p51重组形式——与引物tRNA(Lys3)的相互作用、cDNA合成的起始以及抑制剂的作用
Eur J Biochem. 1998 Jan 15;251(1-2):487-95. doi: 10.1046/j.1432-1327.1998.2510487.x.
3
Structural requirements for the binding of tRNA Lys3 to reverse transcriptase of the human immunodeficiency virus type 1.人免疫缺陷病毒1型逆转录酶结合tRNA Lys3的结构要求
J Biol Chem. 1995 Oct 6;270(40):23867-74. doi: 10.1074/jbc.270.40.23867.
4
Initiation of HIV-2 reverse transcription: a secondary structure model of the RNA-tRNA(Lys3) duplex.HIV-2逆转录的起始:RNA-tRNA(Lys3)双链体的二级结构模型。
Nucleic Acids Res. 2001 Jul 1;29(13):2757-65. doi: 10.1093/nar/29.13.2757.
5
tRNA(Lys3): the primer tRNA for reverse transcription in HIV-1.tRNA(赖氨酸3):HIV-1逆转录的引物tRNA。
IUBMB Life. 2002 Feb;53(2):107-14. doi: 10.1080/15216540211469.
6
HIV-1 reverse transcriptase shows no specificity for the binding of primer tRNA(Lys3).HIV-1逆转录酶对引物tRNA(Lys3)的结合没有特异性。
Biochem Biophys Res Commun. 1996 Aug 23;225(3):839-43. doi: 10.1006/bbrc.1996.1260.
7
Structural constraints in the HIV-1 reverse transcriptase-primer/template complex for the initiation of DNA synthesis from primer tRNALys3.HIV-1逆转录酶-引物/模板复合物中用于从引物tRNALys3起始DNA合成的结构限制因素。
Biochemistry. 1998 Sep 22;37(38):13343-8. doi: 10.1021/bi980239g.
8
On the importance of the primer activation signal for initiation of tRNA(lys3)-primed reverse transcription of the HIV-1 RNA genome.关于引物激活信号在HIV-1 RNA基因组的tRNA(lys3)引发逆转录起始中的重要性
Nucleic Acids Res. 2003 Sep 1;31(17):5186-94. doi: 10.1093/nar/gkg714.
9
Evaluation of human immunodeficiency virus type 1 reverse transcriptase primer tRNA binding by fluorescence spectroscopy: specificity and comparison to primer/template binding.通过荧光光谱法评估1型人类免疫缺陷病毒逆转录酶与引物tRNA的结合:特异性及与引物/模板结合的比较
Biochemistry. 1996 Apr 9;35(14):4609-18. doi: 10.1021/bi9526387.
10
Forced selection of a human immunodeficiency virus type 1 variant that uses a non-self tRNA primer for reverse transcription: involvement of viral RNA sequences and the reverse transcriptase enzyme.强制选择一种使用非自身tRNA引物进行逆转录的1型人类免疫缺陷病毒变体:病毒RNA序列和逆转录酶的作用
J Virol. 2004 Oct;78(19):10706-14. doi: 10.1128/JVI.78.19.10706-10714.2004.

引用本文的文献

1
Advances in chaperone-assisted RNA crystallography using synthetic antibodies.使用合成抗体的伴侣蛋白辅助RNA晶体学研究进展。
BBA Adv. 2023 Aug 19;4:100101. doi: 10.1016/j.bbadva.2023.100101. eCollection 2023.
2
General Strategies for RNA X-ray Crystallography.RNA 晶体 X 射线衍射的一般策略。
Molecules. 2023 Feb 23;28(5):2111. doi: 10.3390/molecules28052111.
3
Synthetic tRNALys,3 as the replication primer for the HIV-1HXB2 and HIV-1Mal genomes.合成的赖氨酸tRNA,3作为HIV-1 HXB2和HIV-1 Mal基因组的复制引物。
Nucleic Acids Res. 2004 Sep 1;32(15):4687-95. doi: 10.1093/nar/gkh813. Print 2004.
4
Structure of HIV-1 reverse transcriptase bound to an inhibitor active against mutant reverse transcriptases resistant to other nonnucleoside inhibitors.与一种对抵抗其他非核苷类抑制剂的突变逆转录酶具有活性的抑制剂结合的HIV-1逆转录酶的结构。
Proc Natl Acad Sci U S A. 2004 Jul 20;101(29):10548-53. doi: 10.1073/pnas.0404151101. Epub 2004 Jul 12.

本文引用的文献

1
Crystal structure of HIV-1 reverse transcriptase in complex with a polypurine tract RNA:DNA.与多聚嘌呤序列RNA:DNA复合物结合的HIV-1逆转录酶的晶体结构
EMBO J. 2001 Mar 15;20(6):1449-61. doi: 10.1093/emboj/20.6.1449.
2
NMR and biochemical characterization of recombinant human tRNA(Lys)3 expressed in Escherichia coli: identification of posttranscriptional nucleotide modifications required for efficient initiation of HIV-1 reverse transcription.在大肠杆菌中表达的重组人tRNA(Lys)3的核磁共振和生化特性:鉴定HIV-1逆转录有效起始所需的转录后核苷酸修饰
RNA. 2000 Oct;6(10):1403-12. doi: 10.1017/s1355838200000947.
3
The crystal structure of HIV reverse-transcription primer tRNA(Lys,3) shows a canonical anticodon loop.HIV逆转录引物tRNA(Lys,3)的晶体结构显示出一个典型的反密码子环。
RNA. 2000 Oct;6(10):1347-55. doi: 10.1017/s1355838200000911.
4
Inhibition of the initiation of HIV-1 reverse transcription by 3'-azido-3'-deoxythymidine. Comparison with elongation.3'-叠氮-3'-脱氧胸苷对HIV-1逆转录起始的抑制作用。与延伸作用的比较。
J Biol Chem. 2000 Sep 1;275(35):26944-51. doi: 10.1074/jbc.M003262200.
5
Initiation of minus-strand DNA synthesis by human immunodeficiency virus type 1 reverse transcriptase.1型人类免疫缺陷病毒逆转录酶引发负链DNA合成
Biochemistry. 1999 Nov 30;38(48):15978-85. doi: 10.1021/bi990945x.
6
High-performance liquid chromatography purification of homogenous-length RNA produced by trans cleavage with a hammerhead ribozyme.利用锤头状核酶进行反式切割产生的均一长度RNA的高效液相色谱纯化。
RNA. 1999 Sep;5(9):1259-67. doi: 10.1017/s1355838299990945.
7
High-resolution preparative-scale purification of RNA using the Prep Cell.使用Prep Cell进行RNA的高分辨率制备规模纯化。
Anal Biochem. 1999 Apr 10;269(1):216-8. doi: 10.1006/abio.1999.4030.
8
Role of post-transcriptional modifications of primer tRNALys,3 in the fidelity and efficacy of plus strand DNA transfer during HIV-1 reverse transcription.引物tRNALys,3的转录后修饰在HIV-1逆转录过程中正义链DNA转移的保真度和效率中的作用
J Biol Chem. 1999 Feb 12;274(7):4412-20. doi: 10.1074/jbc.274.7.4412.
9
Structure and functional implications of the polymerase active site region in a complex of HIV-1 RT with a double-stranded DNA template-primer and an antibody Fab fragment at 2.8 A resolution.HIV-1逆转录酶与双链DNA模板引物及抗体Fab片段复合物中聚合酶活性位点区域在2.8埃分辨率下的结构与功能意义
J Mol Biol. 1998 Dec 11;284(4):1095-111. doi: 10.1006/jmbi.1998.2208.
10
Structure of a covalently trapped catalytic complex of HIV-1 reverse transcriptase: implications for drug resistance.HIV-1逆转录酶的共价捕获催化复合物结构:对耐药性的影响
Science. 1998 Nov 27;282(5394):1669-75. doi: 10.1126/science.282.5394.1669.